oxymorphone hydrochloride

Generic: oxymorphone hydrochloride

Labeler: camber pharmaceuticals, inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxymorphone hydrochloride
Generic Name oxymorphone hydrochloride
Labeler camber pharmaceuticals, inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

oxymorphone hydrochloride 5 mg/1

Manufacturer
Camber Pharmaceuticals, Inc

Identifiers & Regulatory

Product NDC 31722-929
Product ID 31722-929_53da63d9-6ef9-4feb-b704-5b7ef1785f6c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210175
DEA Schedule cii
Listing Expiration 2026-12-31
Marketing Start 2018-03-01

Pharmacologic Class

Classes
full opioid agonists [moa] opioid agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722929
Hyphenated Format 31722-929

Supplemental Identifiers

RxCUI
977939 977942
UPC
0331722930017 0331722929011
UNII
5Y2EI94NBC

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxymorphone hydrochloride (source: ndc)
Generic Name oxymorphone hydrochloride (source: ndc)
Application Number ANDA210175 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (31722-929-01)
source: ndc

Packages (1)

Ingredients (1)

oxymorphone hydrochloride (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "53da63d9-6ef9-4feb-b704-5b7ef1785f6c", "openfda": {"upc": ["0331722930017", "0331722929011"], "unii": ["5Y2EI94NBC"], "rxcui": ["977939", "977942"], "spl_set_id": ["06af7dff-c261-4c03-9cd9-0605c42507fa"], "manufacturer_name": ["Camber Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-929-01)", "package_ndc": "31722-929-01", "marketing_start_date": "20180301"}], "brand_name": "OXYMORPHONE HYDROCHLORIDE", "product_id": "31722-929_53da63d9-6ef9-4feb-b704-5b7ef1785f6c", "dosage_form": "TABLET", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "31722-929", "dea_schedule": "CII", "generic_name": "OXYMORPHONE HYDROCHLORIDE", "labeler_name": "Camber Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXYMORPHONE HYDROCHLORIDE", "active_ingredients": [{"name": "OXYMORPHONE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA210175", "marketing_category": "ANDA", "marketing_start_date": "20180301", "listing_expiration_date": "20261231"}